Analytical Data
-
基因名
Cr1l
- Application
-
别名
Cr1l；Complement component receptor 1-like Protein
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q2VPA4
-
表达区间
33-569aa
-
氨基酸序列
DQCNVPEW LPFARPTNLT DDFEFPIGTY LNYECRPGYS GRPFSIICLK NSVWTSAKDK CKRKSCRNPP DPVNGMAHVI KDIQFRSQIK YSCPKGYRLI GSSSATCIIS GNTVIWDNKT PVCDRIICGL PPTIANGDFT SISREYFHYG SVVTYHCNLG SRGKKVFELV GEPSIYCTSK DDQVGIWSGP APQCIIPNKC TPPNVENGIL VSDNRSLFSL NEVVEFRCQP GFGMKGPSHV KCQALNKWEP ELPSCSRVCQ PPPDVLHAER TQRDKDNFSP GQEVFYSCEP GYDLRGSTYL HCTPQGDWSP AAPRCEVKSC DDFLGQLPNG HVLFPLNLQL GAKVDFVCDE GFQLKGSSAS YCVLAGMESL WNSSVPVCER KSCETPPVPV NGMVHVITDI HVGSRINYSC TTGHRLIGHS SAECILSGNT AHWSMKPPIC QQIFCPNPPA ILNGRHTGTP LGDIPYGKEV SYTCDPHPDR GMTFNLIGES TIRRTSEPHG NGVWSSPAPR CELPVGAGSH DALIVGKFYE VFAEEFCHL
-
分子量
62.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Cr1l, or complement component receptor 1-like, is a protein that plays a significant role in the immune system's regulatory mechanisms. Originally identified in the context of innate immunity, Cr1l is involved in the processing and clearance of immune complexes, thereby contributing to inflammation and immune response modulation. Studies have shown that Cr1l is expressed in various tissues, including the liver and immune cells, indicating its potential role in both systemic and localized immune regulation. Recent research has focused on understanding the molecular structure of Cr1l and its interactions with other components of the immune system, revealing its complex role in diseases such as autoimmunity, infections, and cancer. By studying Cr1l's function and pathways, researchers aim to uncover new therapeutic strategies that could enhance immune responses in patients or mitigate excessive inflammation. The ongoing exploration of Cr1l as a recombinant protein offers the potential for innovative approaches in vaccine development, immune therapies, and biomarker identification. Overall, the investigation of Cr1l serves as a promising frontier in immunology, with implications for better understanding and treating a variety of immune-related conditions.
